Inactive Instrument

Global Cord Blood Corporation Share Price Deutsche Boerse AG

Equities

6CB

KYG393421030

Healthcare Facilities & Services

Financials

Sales 2021 115.96Cr 16Cr 15Cr 1.33TCr Sales 2022 124.33Cr 17Cr 16Cr 1.43TCr Capitalization 296.79Cr 41Cr 38Cr 3.42TCr
Net income 2021 51Cr 7.02Cr 6.49Cr 584.55Cr Net income 2022 50Cr 6.92Cr 6.4Cr 576.49Cr EV / Sales 2021 -2.13 x
Net cash position 2021 607.4Cr 84Cr 78Cr 6.99TCr Net cash position 2022 666.08Cr 92Cr 85Cr 7.66TCr EV / Sales 2022 -2.97 x
P/E ratio 2021
7.1 x
P/E ratio 2022
5.93 x
Employees 1,202
Yield 2021 *
-
Yield 2022
-
Free-Float 38.41%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 52 01/09/01
Director of Finance/CFO 48 01/09/01
Chief Tech/Sci/R&D Officer 70 01/04/01
Members of the board TitleAgeSince
Director/Board Member 56 01/09/01
Chief Executive Officer 52 01/09/01
Director/Board Member 56 01/09/01
More insiders
Global Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.
More about the company